McKesson : TRUQAP (capivasertib), FDA Approved for the Treatment of Breast Cancer, Available at Biologics by McKesson -December 01, 2023 at 04:07 pm EST

CARY, N.C., Dec. 1, 2023-Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by AstraZeneca as a specialty pharmacy...

Related Keywords

Claire Crye ,Specialty Pharmacy Solutions ,Drug Administration ,Mckesson ,Us Oncology Research ,Us Oncology Network ,Astrazeneca ,Sarah Cannon Research Institute ,Mckesson Provider Solutions ,Specialty Solutions ,Mckesson Corporation ,Ela Lourido ,Mckesson Oncology ,Sarah Cannon Research ,Markets ,